Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000039

President and CEO sold 7,818 shares at $19.78 ($154,640)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-09 Sale : show line 1 in the form −7,818 $19.78 $154,640 2,268,363 I
Open-market sales · 7,818 sh · avg $19.78 · $154,640
Loading xslF345X05/wk-form4_1705012085.xml…